Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.

Saved in:
Bibliographic Details
Title: Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.
Authors: Aizenbud L; Medical Oncology, Yale University, New Haven, Connecticut, USA., Savion Gaiger N; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Perdigoto AL; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Internal medicine, VA Connecticut Healthcare System, West Haven, Connecticut, USA., Mann JE; Medical Oncology, Yale University, New Haven, Connecticut, USA., Torres MC; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA., Boland GM; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA., Lawless AR; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Silverman S; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA., Schoenfeld DA; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Destina JI; Yale University, New Haven, Connecticut, USA., Hasson N; Medical Oncology, Yale University, New Haven, Connecticut, USA., Tran T; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Hurwitz M; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Austin MR; Medical Oncology, Yale University, New Haven, Connecticut, USA., Sullivan RJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Herold KC; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Immunology, Yale University, New Haven, Connecticut, USA., Kluger HM; Medical Oncology, Yale University, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Sep 10; Vol. 13 (9). Date of Electronic Publication: 2025 Sep 10.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-012358